The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis

Journal of Biological Chemistry

Volumn 288, Issue 33, 2013, Pages 23833-23843

  Lu, Huarui ^a   Hallstrom, Timothy C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMORS; INDUCED APOPTOSIS; NUCLEAR PROTEINS; TUMOR SUPPRESSORS;

TUMORS;

CELL DEATH;

MESSENGER RNA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR E2F1; UBIQUITIN LIKE WITH PHD AND RING FINGER DOMAIN 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; UBIQUITIN LIKE WITH PHD AND RING FINGER DOMAIN 2 GENE;

APOPTOSIS; E2F TRANSCRIPTION FACTOR; GENE EXPRESSION; SHRNA; TRANSCRIPTION TARGET GENES; UHRF2;

APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENETIC TESTING; HUMANS; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; REPRODUCIBILITY OF RESULTS; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES;

EID: 84882297904     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.447276     Document Type: Article

References (46)

1. Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., and Dean, D. C. (2000) Exit fromG1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/ SNF and Rb-hSWI/SNF. Cell 101, 79-89
2. Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M., and Nakatani, Y. (2002) A complex with chromatin modifiers that occupies E2F-and Mycresponsive genes in G0 cells. Science 296, 1132-1136
3. Wu, X., and Levine, A. J. (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91, 3602-3606
4. Hallstrom, T. C., and Nevins, J. R. (2003) Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100, 10848-10853
5. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., and Vousden, K. H. (1998) p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125
6. Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., and Kaelin, W. G., Jr. (2000) Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648
7. Stiewe, T., and Pützer, B. M. (2000) Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat. Genet. 26, 464-469
8. Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G., and Dowdy, S. F. (2000) A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407, 642-645
9. Moroni, M. C., Hickman, E. S., Lazzerini Denchi, E., Caprara, G., Colli, E., Cecconi, F., Müller, H., and Helin, K. (2001) Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3, 552-558
10. Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., Narita, M., Zhang, M. Q., Lazebnik, Y., Bar-Sagi, D., and Lowe, S. W. (2002) Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4, 859-864
11. Rogoff, H. A., Pickering, M. T., Debatis, M. E., Jones, S., and Kowalik, T. F. (2002) E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol. Cell. Biol. 22, 5308-5318
12. Croxton, R., Ma, Y., Song, L., Haura, E. B., and Cress, W. D. (2002) Direct repression of the Mcl-1 promoter by E2F1. Oncogene 21, 1359-1369
13. Hershko, T., and Ginsberg, D. (2004) Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J. Biol. Chem. 279, 8627-8634
14. Rodriguez, J. M., Glozak, M. A., Ma, Y., and Cress, W. D. (2006) Bok, Bcl-2-related ovarian killer, is cell cycle-regulated and sensitizes to stressinduced apoptosis. J. Biol. Chem. 281, 22729-22735
15. Tracy, K., Dibling, B. C., Spike, B. T., Knabb, J. R., Schumacker, P., and Macleod, K. F. (2007) BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol. Cell. Biol. 27, 6229-6242
16. Li, Y., Mori, T., Hata, H., Homma, Y., and Kochi, H. (2004) NIRF induces G1 arrest and associates with Cdk2. Biochem. Biophys. Res. Commun. 319, 464-468
17. Bronner, C., Achour, M., Arima, Y., Chataigneau, T., Saya, H., and Schini-Kerth, V. B. (2007) The UHRF family. Oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol. Ther. 115, 419-434
18. Pichler, G., Wolf, P., Schmidt, C. S., Meilinger, D., Schneider, K., Frauer, C., Fellinger, K., Rottach, A., and Leonhardt, H. (2011) Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic pathways. J. Cell Biochem. 112, 2585-2593
19. Zhang, J., Gao, Q., Li, P., Liu, X., Jia, Y., Wu, W., Li, J., Dong, S., Koseki, H., and Wong, J. (2011) S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 inDNAmethylation maintenance. Cell Res. 21, 1723-1739
20. Jeanblanc, M., Mousli, M., Hopfner, R., Bathami, K., Martinet, N., Abbady, A. Q., Siffert, J. C., Mathieu, E., Muller, C. D., and Bronner, C. (2005) The retinoblastoma gene and its product are targeted by ICBP90. A key mechanism in the G1/S transition during the cell cycle. Oncogene 24, 7337-7345
21. Mori, T., Ikeda, D. D., Fukushima, T., Takenoshita, S., and Kochi, H. (2011) NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor. Cell Cycle 10, 3284-3299
22. Morita, S., Kojima, T., and Kitamura, T. (2000) Plat-E. An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066
23. Silva, J. M., Li, M. Z., Chang, K., Ge, W., Golding, M. C., Rickles, R. J., Siolas, D., Hu, G., Paddison, P. J., Schlabach, M. R., Sheth, N., Bradshaw, J., Burchard, J., Kulkarni, A., Cavet, G., Sachidanandam, R., McCombie, W. R., Cleary, M. A., Elledge, S. J., and Hannon, G. J. (2005) Secondgeneration shRNA libraries covering the mouse and human genomes. Nat. Genet. 37, 1281-1288
24. Nelson, J. D., Denisenko, O., and Bomsztyk, K. (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1, 179-185
25. Mousli, M., Hopfner, R., Abbady, A. Q., Monté, D., Jeanblanc, M., Oudet, P., Louis, B., and Bronner, C. (2003) ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br. J. Cancer 89, 120-127
26. Hellerbrand, C., Amann, T., Schlegel, J., Wild, P., Bataille, F., Spruss, T., Hartmann, A., and Bosserhoff, A. K. (2008) The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut 57, 243-251
27. Filimonenko, M., Isakson, P., Finley, K. D., Anderson, M., Jeong, H., Melia, T. J., Bartlett, B. J., Myers, K. M., Birkeland, H. C., Lamark, T., Krainc, D., Brech, A., Stenmark, H., Simonsen, A., and Yamamoto, A. (2010) The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol. Cell 38, 265-279
28. Mudryj, M., Devoto, S. H., Hiebert, S. W., Hunter, T., Pines, J., and Nevins, J. R. (1991) Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65, 1243-1253
29. Bandara, L. R., Adamczewski, J. P., Hunt, T., and La Thangue, N. B. (1991) Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352, 249-251
30. Koguchi, K., Kobayashi, S., Hayashi, T., Matsufuji, S., Murakami, Y., and Hayashi, S. (1997) Cloning and sequencing of a human cDNA encoding ornithine decarboxylase antizyme inhibitor. Biochim. Biophys. Acta 1353, 209-216
31. Zender, L., Xue, W., Zuber, J., Semighini, C. P., Krasnitz, A., Ma, B., Zender, P., Kubicka, S., Luk, J. M., Schirmacher, P., McCombie, W. R., Wigler, M., Hicks, J., Hannon, G. J., Powers, S., and Lowe, S. W. (2008) An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135, 852-864
32. Clement, P. M., Henderson, C. A., Jenkins, Z. A., Smit-McBride, Z., Wolff, E. C., Hershey, J. W., Park, M. H., and Johansson, H. E. (2003) Identification and characterization of eukaryotic initiation factor 5A-2. Eur. J. Biochem. 270, 4254-4263
33. Hu, J., Yuan, W., Tang, M., Wang, Y., Fan, X., Mo, X., Li, Y., Ying, Z., Wan, Y., Ocorr, K., Bodmer, R., Deng, Y., and Wu, X. (2010) KBTBD7, a novel human BTB-kelch protein, activates transcriptional activities of SRE and AP-1. BMB Rep. 43, 17-22
34. Mori, T., Li, Y., Hata, H., Ono, K., and Kochi, H. (2002) NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem. Biophys. Res. Commun. 296, 530-536
35. Rothbart, S. B., Krajewski, K., Nady, N., Tempel, W., Xue, S., Badeaux, A. I., Barsyte-Lovejoy, D., Martinez, J. Y., Bedford, M. T., Fuchs, S. M., Arrowsmith, C. H., and Strahl, B. D. (2012) Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat. Struct. Mol. Biol. 19, 1155-1160
36. Unoki, M., Brunet, J., and Mousli, M. (2009) Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem. Pharmacol. 78, 1279-1288
37. Bostick, M., Kim, J. K., Estève, P. O., Clark, A., Pradhan, S., and Jacobsen, S. E. (2007) UHRF1 plays a role in maintainingDNAmethylation in mammalian cells. Science 317, 1760-1764
38. Sharif, J., Muto, M., Takebayashi, S., Suetake, I., Iwamatsu, A., Endo, T. A., Shinga, J., Mizutani-Koseki, Y., Toyoda, T., Okamura, K., Tajima, S., Mitsuya, K., Okano, M., and Koseki, H. (2007) The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450, 908-912
39. Hashimoto, H., Horton, J. R., Zhang, X., Bostick, M., Jacobsen, S. E., and Cheng, X. (2008) The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 455, 826-829
40. Avvakumov, G. V., Walker, J. R., Xue, S., Li, Y., Duan, S., Bronner, C., Arrowsmith, C. H., and Dhe-Paganon, S. (2008) Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 455, 822-825
41. Arita, K., Ariyoshi, M., Tochio, H., Nakamura, Y., and Shirakawa, M. (2008) Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 455, 818-821
42. Muto, M., Kanari, Y., Kubo, E., Takabe, T., Kurihara, T., Fujimori, A., and Tatsumi, K. (2002) Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J. Biol. Chem. 277, 34549-34555
43. Hervouet, E., Lalier, L., Debien, E., Cheray, M., Geairon, A., Rogniaux, H., Loussouarn, D., Martin, S. A., Vallette, F. M., and Cartron, P. F. (2010) Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS One. 5, e11333
44. Jenkins, Y., Markovtsov, V., Lang, W., Sharma, P., Pearsall, D., Warner, J., Franci, C., Huang, B., Huang, J., Yam, G. C., Vistan, J. P., Pali, E., Vialard, J., Janicot, M., Lorens, J. B., Payan, D. G., and Hitoshi, Y. (2005) Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol. Biol. Cell 16, 5621-5629
45. Unoki, M., Nishidate, T., and Nakamura, Y. (2004) ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23, 7601-7610
46. Mori, T., Li, Y., Hata, H., and Kochi, H. (2004) NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP, a PEST-containing nuclear protein. FEBS Lett. 557, 209-214